Paul J. Mellett, Treasurer and CFO at ENANTA PHARMACEUTICALS INC (ENTA), sold 27,100 shares at $121.42 ($3.3M) on 2018-06-11, disclosed to the SEC on 2018-06-12.
Open-market sale of $3.3M ENTA by Treasurer and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.52 | 300 | $35K | 1.1% |
| 2 | $119.35 | 2,600 | $310K | 9.5% |
| 3 | $120.37 | 6,336 | $763K | 23.3% |
| 4 | $120.37 | 6,336 | $763K | 23.3% |
| 5 | $121.42 | 5,153 | $626K | 19.1% |
| 6 | $121.42 | 5,153 |
| $626K |
| 19.1% |
| 7 | $122.17 | 611 | $75K | 2.3% |
| 8 | $122.17 | 611 | $75K | 2.3% |
| Total | $120.72 avg | 27,100 | $3.3M | 100% |
| Filing → |
| ENTA | SELL | 2023-03-17 | $923K | — | Filing → |
| ENTA | SELL | 2023-02-13 | $269K | — | Filing → |
| ENTA | SELL | 2021-01-08 | $273K | — | Filing → |